Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | FPR1 | P21462 | 2/20 | 0.40 |
| ▸ | FPR2 | P25090 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | COMT | P21964 | 1/20 | 0.39 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24718259 | 0.93 | SRC (0.43) | SRCHDAC11FPR1FPR2SIGMAR1 | |
| SCHEMBL24719135 | 0.85 | HDAC11 (0.46) | SRCHDAC11SIGMAR1KDM4EALDH1A1 | |
| SCHEMBL24718654 | 0.84 | TMPRSS4 (0.44) | SIGMAR1EPHX2 | |
| SCHEMBL24718848 | 0.81 | P2RX7 (0.41) | HDAC11SIGMAR1KMT2ASIRT2SIRT1 | |
| SCHEMBL24718420 | 0.77 | SRC (0.49) | SRCSIGMAR1KDM4EALDH1A1MEN1 | |
| SCHEMBL24718296 | 0.77 | SRC (0.49) | SRCSIGMAR1KDM4EALDH1A1MEN1 | |
| SCHEMBL24718308 | 0.77 | SRC (0.49) | SRCSIGMAR1KDM4EALDH1A1MEN1 | |
| SCHEMBL24718433 | 0.74 | CRHR1 (0.41) | KMT2ASIRT2SIRT1 | |
| SCHEMBL24718382 | 0.74 | TP53 (0.46) | HDAC11SIGMAR1SCN9ATEAD1ALDH1A1 | |
| SCHEMBL24718241 | 0.74 | TP53 (0.46) | HDAC11SIGMAR1SCN9ATEAD1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220363633-A1 | SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING | UNITED STATES GOVERNMENT | 2022-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363633-A1 | SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING | EED, EZH2, ELP1 | SRC 1194/4885HDAC11 224/4885FPR1 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.